REG - ConvaTec Group PLC - Annual Report and Accounts 2021 and Notice of AGM

ConvaTecAnnouncement

30/03/2022 12:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220330:nRSd6102Ga&default-theme=true

RNS Number : 6102G  ConvaTec Group PLC  30 March 2022

Publication of Annual Report and Accounts 2021

and Notice of Meeting

 

 

READING, UNITED KINGDOM (30 March 2022) - ConvaTec Group Plc ("ConvaTec"
or the "Group"), a global medical products and technologies company, today
announces that the following documents are now available on its website
at www.convatecgroup.com (http://www.convatecgroup.com/) .

 

-      Annual Report and Accounts 2021

-      Notice of Annual General Meeting

-      Form of Proxy

 

In compliance with Listing Rule 9.6.1, copies of the Annual Report and
Accounts 2021,  Notice of Annual General Meeting and Form of Proxy, will be
submitted to the National Storage Mechanism and will, in due course, be
available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

Printed copies of these documents will be sent to shareholders who have
requested hard copies in due course.

 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations, ConvaTec
   +44 (0)782 644 7807

ir@convatec.com (mailto:ir@convatec.com)

 

Media

Buchanan: Charles Ryland / Chris Lane
               +44 (0)207 466 5000
 
 
 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on
solutions for the management of chronic conditions, with leading market
positions in advanced wound care, ostomy care, continence and critical care,
and infusion care. Our products provide a range of clinical and economic
benefits including infection prevention, protection of at-risk skin, improved
patient outcomes and reduced total cost of care. To learn more about ConvaTec,
please visit www.convatecgroup.com (http://www.convatecgroup.com/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSKZGFFGGNGZZM